Genome & Company Email Formats
Biotechnology Research • 
Changnyong-daero 256beon-gil, 50, Korea, Republic of • 51-100 Employees
Genome & Company Email Formats
Genome & Company uses 3 email formats. The most common is {first name} (e.g., john@genomecom.co.kr), used 66.7% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name} | john@genomecom.co.kr | 66.7% |
{first initial}.{last name} | j.doe@genomecom.co.kr | 16.7% |
{second initial} | o@genomecom.co.kr | 16.7% |
Key Contacts at Genome & Company
Y. S. Hong
Chief Executive Officer
Jisoo Pae
Chief Executive Officer
Won Jun Lee
Associate Director
Company overview
| Headquarters | Changnyong-daero 256beon-gil, 50, 광교플렉스데시앙, Suwon-si, Gyeonggi-Do 13486, KR |
| Phone number | +827048213840 |
| Website | |
| NAICS | 541714 |
| SIC | 873 |
| Keywords | Research And Development, Immuno-Oncology, Microbiome, Genome And Company, Immune Checkpoint Inhibitors, 마이크로바이옴, 맞춤형면역항암제, 면역항함제, 지놈앤컴퍼니, 항체개발, 임상개발, 신규타깃 면역항암제 |
| Founded | 2015 |
| Employees | 51-100 |
| Socials |
About Genome & Company
Genome & Company is a global biopharmaceutical company that focuses on developing microbiome pharmaceuticals, consumer products and novel immune checkpoint inhibitors based on real-world clinical data and Multi-Omics analytic technology. Since its establishment in 2015, as a global leader in the field of microbiome for immuno-oncology and novel drug discovery for immuno-oncology target, Genome & Company has been collaborating with global pharmaceutical companies, research institutions and hospitals in Korea based on the “Bed-to-Bench” approach (real-world clinical data driven R&D strategy) of GNOCLE™, a platform for discovering novel drug candidates. Genome & Co strives to accelerate the development of innovative medicine to fulfill the medical unmet needs through microbiome therapeutics and novel drug target antibodies. 지놈앤컴퍼니는 풍부한 임상데이터 및 다중오믹스 기술(Multi-Omics)을 바탕으로 마이크로바이옴 의약품과 신규 타깃 항암제 등을 중점 연구개발하는 글로벌 신약개발 전문기업 입니다. 2015년 설립이후, 지놈앤컴퍼니는 마이크로바이옴 면역항암제와 신규타깃 면역항암제 분야의 글로벌 리더로서 독자 신약후보물질 발굴 플랫폼 지노클(GNOCLE™)의 'Bed-to-Bench' 전략 (임상데이터기반 연구개발전략) 하에 국내외 주요 제약바이오 기업 및 연구중심병원과 협업해왔습니다.
Employees by Management Level
Total employees: 51-100
Seniority
Employees
Employees by Department
Genome & Company has 9 employees across 6 departments.
Departments
Number of employees
Funding Data
Genome & Company has never raised funding before.
Genome & Company Tech Stack
Discover the technologies and tools that power Genome & Company's digital infrastructure, from frameworks to analytics platforms.
Reverse proxies
Argentina
United States
Netherlands
United Kingdom
Frequently asked questions
4.8
40,000 users
